Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation termination factor 1 pseudogene 1 (ETF1P1)
- Target
- ETF1P1
- Molecular classification
- Other (pseudogene)
01
Overview
Eukaryotic translation termination factor 1 pseudogene 1 (ETF1P1) is a human pseudogene related to eukaryotic translation termination factor 1 (ETF1), which is an essential class-1 polypeptide chain release factor responsible for translation termination at stop codons. ETF1P1 itself does not encode for a functional protein. Like many pseudogenes, ETF1P1 is considered a nonfunctional relic of a protein-coding gene. Although some pseudogenes have emerging regulatory roles in gene expression (e.g., through acting as microRNA sponges or by generating regulatory noncoding RNAs), there is no direct evidence that ETF1P1 has any such functional impact. Its aliases include HCGVII and SUP45L2. ETF1P1 should not be confused with ETF1 (eukaryotic translation termination factor 1), which is a functional gene and an essential component of translation termination machinery.
- Other names
- HCGVIISUP45L2
02
Biological functions
Other (no direct biological function; as a pseudogene, may have potential RNA-mediated regulatory roles, but does not encode a functional protein)
03
Disease associations
Other (no direct, well-established disease association; some pseudogenes can regulate coding genes or participate in competing endogenous RNA networks, but ETF1P1 itself does not have a documented functional or pathological role as of current databases)
Beyond the preview
Go deeper on Eukaryotic translation termination factor 1 pseudogene 1 (ETF1P1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eukaryotic translation termination factor 1 pseudogene 1 (ETF1P1).